Search
01/12/2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective
de Bruin-Weller, M, Merola, JF, Hong, CH, Baldrich, ES, Ettler, K, Sierka, D, Delevry, D, Chen, Z, Rossi, AB. Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective. Dermatology and Therapy. 2021; 11(6)DOI:10.1007/s13555-021-00621-w. PMID:34767181. IF:3.661(Q2/3D).
01/12/2021
Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up
Papp, KA, Lebwohl, MG, Puig, L, Ohtsuki, M, Beissert, S, Zeng, J, Rubant, S, Sinvhal, R, Zhao, Y, Soliman, AM, Alperovich, G, Leonardi, C. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. BRITISH JOURNAL OF DERMATOLOGY. 2021; 185(6)DOI:10.1111/bjd.20595. PMID:34157132. IF:11.113(Q1/1D).
01/11/2021
Diagnostic Value of Cutaneous Ultrasound in Verrucous Venous Malformation
Amat-Samaranch, V, Morales-Munera, C, Puig, L, Roe, E. Diagnostic Value of Cutaneous Ultrasound in Verrucous Venous Malformation. Actas Dermo-Sifiliograficas. 2021; 112(10)DOI:10.1016/j.ad.2021.07.002. PMID:. IF:(Q/D).
01/11/2021
Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study"
Torres, T, Chiricozzi, A, Puig, L. Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study". AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2021; 22(6)DOI:10.1007/s40257-021-00640-5. PMID:34705165. IF:6.233(Q1/2D).
01/11/2021
Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnet
Cubiro, X, Garcia-Melendo, C, Morales-Munera, CE, Roe-Crespo, E, Riera-Mestre, A, Mora-Lujan, JM, Iriarte, A, Puig, L, Baselga, E. Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnet. Dermatologic Therapy. 2021; 34(6)DOI:10.1111/dth.15124. PMID:34486206. IF:3.858(Q2/3D).
01/11/2021
Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"
Mercader-Garcia, P, Pastor-Nieto, MA, Gonzalez-Perez, R, Gimenez-Arnau, AM, Ruiz-Gonzalez, I, Mora-Fernandez, V, Miquel, J, Silvestre-Salvador, JF, Sanz-Sanchez, T, Perez-Feal, P, Sanchez-Perez, J, Heras-Mendaza, F, Serra-Baldrich, E, Hervella-Garces, M, Gatica-Ortega, ME, Garcia-Doval, I, Borrego, L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". CONTACT DERMATITIS. 2021; 85(5)DOI:10.1111/cod.13941. PMID:34268785. IF:6.419(Q1/1D).